売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2024/12 |
1,336 |
- |
| 2023/12 |
910 |
- |
| 2022/12 |
540 |
- |
| 2021/12 |
1,263 |
- |
| 2020/12 |
828 |
- |
| 2019/12 |
|
|
| 2018/12 |
|
|
| 2017/12 |
|
|
| 2016/12 |
|
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/12 |
-1,442 |
-108.0% |
| 2023/12 |
-2,033 |
-223.5% |
| 2022/12 |
-2,625 |
-486.4% |
| 2021/12 |
-1,839 |
-145.6% |
| 2020/12 |
-2,577 |
-311.1% |
| 2019/12 |
|
|
| 2018/12 |
|
|
| 2017/12 |
|
|
| 2016/12 |
|
|
| 2015/12 |
|
|
| 2014/12 |
|
|
| 2013/12 |
|
|
| 2012/12 |
|
|
| 2011/12 |
|
|
|
(単位:千ドル)
|
2011/12
|
2012/12
|
2013/12
|
2014/12
|
2015/12
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
2024/12
|
|
売上高
|
-
|
-
|
-
|
-
|
-
|
1,236
|
1,509
|
1,488
|
1,564
|
828
|
1,263
|
539
|
909
|
1,335
|
|
売上成長率(%)
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
|
-47.0
|
52.5
|
-57.3
|
68.5
|
46.8
|
|
研究開発費
|
1,390
|
1,671
|
2,203
|
1,621
|
1,588
|
1,417
|
799
|
863
|
1,035
|
628
|
580
|
609
|
583
|
570
|
|
営業費用
|
5,009
|
5,667
|
8,044
|
6,047
|
6,330
|
5,504
|
3,927
|
3,906
|
4,764
|
3,405
|
3,101
|
3,164
|
2,942
|
2,777
|
|
営業利益
|
-4,164
|
-3,711
|
-5,884
|
-4,449
|
-4,324
|
-4,268
|
-2,419
|
-2,419
|
-3,201
|
-2,578
|
-1,839
|
-2,626
|
-2,034
|
-1,442
|
|
営業利益率 (%)
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
-311.1
|
-145.6
|
-486.4
|
-223.5
|
-108.0
|
|
経常(税引前)利益
|
-
|
-3,677
|
-5,846
|
-4,414
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
法人税等合計
|
-
|
-614
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
実効税率(%)
|
-
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
純利益
|
-4,135
|
-3,064
|
-5,846
|
-4,414
|
-4,280
|
-4,239
|
-2,414
|
-2,687
|
-3,809
|
-2,341
|
-1,847
|
-2,670
|
-1,909
|
-1,312
|
|
純利益率(%)
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
-282.6
|
-146.2
|
-494.6
|
-209.8
|
-98.2
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.08
|
-0.06
|
-0.04
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.08
|
-0.06
|
-0.04
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
-2,511
|
-
|
-
|
-
|
-
|
|
EBITDAマージン(%)
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
-303.0
|
-
|
-
|
-
|
-
|